Arterys Cardio DL vs Cleerly LABS

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Arterys (now part of Tempus)
VS
by Cleerly

AI Verdict

Tool A specializes in automated ventricle segmentations and advanced flow analysis using cardiac MRI, aiming to streamline MRI interpretation. In contrast, Tool B focuses on comprehensive analysis of coronary CT angiography (CCTA) to characterize atherosclerosis and stenosis for personalized heart disease management. While both are AI-powered cardiac imaging tools, their distinct focus on different imaging modalities and specific cardiac structures makes them complementary rather than direct competitors.

Choose Arterys Cardio DL if…

Choose Arterys Cardio DL if your primary need is rapid and accurate analysis of cardiac MRI studies. This cloud-based AI software excels at automated, editable ventricle segmentations, 4D Flow post-processing for blood flow visualization, and quantitative delayed enhancement analysis, significantly reducing interpretation time for comprehensive functional and structural cardiac assessments.

View Arterys Cardio DL →

Choose Cleerly LABS if…

Choose Cleerly LABS if you require comprehensive AI-powered analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis. This web-based software is ideal for personalized heart disease management, offering detailed coronary plaque assessment and the ability to track disease progression over time.

View Cleerly LABS →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Arterys Cardio DL Cleerly LABS
Pricing Unknown Per analysis
Deployment Cloud-based (SaaS), integrates with existing PACS or EHR, web-based zero-footprint viewer (Mac, PC, tablet, phone). [4, 7, 9, 13, 27] Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer.
FDA Status 1 AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Arterys Cardio DL

Arterys Cardio DL emphasizes 'rapid analysis' and 'editable automated contours,' which directly enhance user experience by providing quick results and allowing clinicians to refine AI-generated segmentations. While both are cloud-based, the explicit mention of editable contours suggests a higher degree of user control and flexibility in the diagnostic workflow.

Clinical Value

Cleerly LABS

Cleerly LABS offers a comprehensive approach to coronary CT angiography (CCTA), focusing on detecting, quantifying, and characterizing atherosclerosis and stenosis, which is critical for personalized heart disease management and tracking progression. Its ability to assess plaque volume and type, alongside stenosis and ischemia detection, provides a more holistic view for preventing heart attacks.

Pricing & Value

Cleerly LABS

Cleerly LABS provides transparent pricing information, including a retail price and a discounted offer, allowing potential users to immediately assess the financial implications. In contrast, Arterys Cardio DL requires contacting them for pricing, which makes it harder for prospective customers to evaluate its value proposition upfront.

Enterprise Readiness

Cleerly LABS

Both tools are FDA-cleared, HIPAA compliant, have BAAs, and are cloud-based, indicating strong foundational enterprise readiness. However, Cleerly LABS explicitly highlights 'Integration with PACS, RIS, EHR via Cleerly Proxy,' which demonstrates a more detailed and robust approach to integrating into existing hospital IT infrastructure and clinical workflows.

Innovation

Cleerly LABS

While Arterys Cardio DL boasts being the 'world's first internet platform for medical imaging' and offers advanced 4D Flow post-processing, Cleerly LABS's mission to 'eliminate heart attacks through AI-powered cardiovascular imaging' by comprehensively characterizing plaque and tracking disease progression represents a highly innovative and proactive approach to cardiovascular care. This focus on personalized heart disease management and prevention sets a new standard.

Support & Docs

Tie

Neither the provided structured facts nor readily available web searches offer specific details regarding the depth or nature of support and documentation for either Arterys Cardio DL or Cleerly LABS. Both companies are established and would undoubtedly offer customer support, but without comparative information, it is not possible to determine a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Arterys Cardio DL Cleerly LABS
Tool Name Arterys Cardio DL Cleerly LABS
Company ARTERYS Cleerly
Primary Imaging Modality Cardiac MRI Coronary CT Angiography (CCTA)
Core Functionality Automated, editable ventricle segmentations for cardiac MRI analysis; 4D Flow post-processing; Quantitative Delayed Enhancement analysis Comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis; Ischemia detection (with Cleerly ISCHEMIA module); 3D visualization
Efficiency Claim Rapid analysis (seconds vs. 30-60 minutes) Not specified

Videos

Demos, reviews, and walkthroughs featuring Arterys Cardio DL and Cleerly LABS.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Arterys Cardio DL is designed for automated ventricle segmentations for cardiac MRI analysis. In contrast, Cleerly LABS specializes in comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis.
Arterys Cardio DL focuses on enhancing diagnostic accuracy and reducing interpretation time for cardiac MRI through automated ventricle segmentations, 4D Flow post-processing, and Quantitative Delayed Enhancement analysis. Cleerly LABS aims to aid in personalized heart disease management by detecting, quantifying, and characterizing coronary plaque and stenosis from CCTA, and can also track disease progression over time.
Arterys Cardio DL provides advanced features like 4D Flow post-processing for blood flow visualization and quantification, and Quantitative Delayed Enhancement analysis. Cleerly LABS offers comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with the Cleerly ISCHEMIA module), and 3D visualization of coronary arteries.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.